BACKGROUND: Both unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) are approved for venous thromboembolism (VTE) prophylaxis. Which agent is superior remains controversial.

A phase I study of axitinib (AG-013736), a potent inhibitor of VEGFRs, in combination with gemcitabine (GEM) in patients (pts) with advanced pancreatic cancer No significant financial relationships to ...

Odds of an uncomplicated pregnancy with a live birth were lower for mothers with mechanical valves versus biological valves. Risks from anticoagulation appeared highest with low-molecular-weight ...

Protein S deficiency represents a rare but significant hereditary thrombophilia that poses substantial risks during pregnancy ...

Incidence of mortality in vulnerable and non-vulnerable older patients with cancer. Characteristics and outcomes of the included studies for elderly patients. DOACs= direct oral anticoagulant; LMWH= ...

"The amount of data obtained are overwhelming and will need careful interpretation due to the study's significant implications, which may change the way adjuvant anticoagulation is given to ACS ...

There are few things more exciting for researchers than to mount and complete a clinical trial that could change the practice of medicine and save lives. That’s what we experienced when The New ...

For patients with fracture, guidelines recommend low-molecular-weight heparin to prevent thrombosis, but head-to-head comparisons between low-molecular-weight heparin and aspirin are lacking. New ...